loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 22974 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Interquim SA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    Key Products KEY PRODUCTS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Interquim SA (1)

    filter

    01 RIVASTIGMINE (1)

    filter

    01 Spain (1)

    filter

    01 Active (1)

    filter

    01 Complete (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    INTERQUIM SA

    Contact Supplier
    • FDA
    • EDQM
    • Audit Compliance
    Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
    Contact Supplier Contact Supplier
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RIVASTIGMINE

    PDF Supplier PDF
    URL Supplier Web Content
    Other DMF ASMF, CA, CN, T-DMF
    22974
    Active
    2009-07-22
    Complete
    2013-03-28
    2013-03-20
    II
    Interquim Company Banner

    BIO Int. Convention

    Attending

    envelop Contact Supplier

    Looking for Drug Master Files (DMF) for 22974 of Interquim Sa

    Looking for Drug Master Files (DMF) for 22974 of Interquim Sa 1

    20

    Interquim Sa, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    One of their notable products is RIVASTIGMINE, with a corresponding US DMF Number 22974.

    Remarkably, this DMF maintains an Active status since its submission on July 22, 2009, highlighting commitment to regulatory compliance.

    Their GDUFA DMF Review was successfully complete, with a review date of March 28, 2013, and payment made on March 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II

    Post Enquiry
    POST ENQUIRY